QID 379179

Date Published: 2024-01-25

QID 379179: Elasticsearch Kibana Storage of Sensitive Information into Log File (ESA-2023-27)

Kibana is a source-available data visualization dashboard software for Elasticsearch.

CVE-2023-46675: The messages recorded in the log may contain Account credentials for the kibana_system user, API Keys, and credentials of Kibana end-users, Elastic Security package policy objects which can contain private keys, bearer token, and sessions of 3rd-party integrations and finally Authorization headers, client secrets, local file paths, and stack traces.

Affected Version:
Kibana versions from 7.13.0 to 7.17.15.
Kibana versions from 8.0.0 to 8.11.1.

QID Detection Logic (Authenticated):
This authenticated QID checks for Kibana version by running "kibana --version" command.

QID Detection Logic (Unauthenticated):
This QID sends a GET request to find if the target is running a vulnerable version of kibana.

Successful exploitation of these vulnerabilities may affect confidentiality, integrity and availability of the targeted user.

CVSS V3 rated as High - 6.5 severity.

CVSS V2 rated as High - 6.8 severity.

Solution

Update to version 8.11.2 or 7.17.16. Kibana can be downloaded at Download Kibana 8.11.2

Vendor References

ESA-2023-27 - discuss.elastic.co/t/kibana-8-11-2-7-17-16-security-update-esa-2023-27/349182

CVEs related to QID 379179

CVE-2023-46675 |

Software Advisories

Advisory ID	Software	Component	Link
ESA-2023-27			discuss.elastic.co/t/kibana-8-11-2-7-17-16-security-update-esa-2023-27/349182

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].